News | May 24, 2011

Cordis Launches Two New Products at EuroPCR Congress

May 24, 2011 - Cordis announced it has obtained CE mark for its Empira and Empira NC RX percutaneous transluminal coronary angioplasty (PTCA) dilatation catheters for the treatment of coronary artery disease. The Empira systems are designed to enable interventional cardiologists to open patients' narrowed coronary arteries during angioplasty and stenting procedures. The company also highlighted its radial access products at EuroPCR 2011.

The Empira family of PTCA dilatation catheters incorporates several design and technology changes that have the potential to improve crossability and recrossability, allowing a physician to reach even hard-to-treat lesions. Both catheters utilize the next generation Dralyn Flex balloon material, which is 50 percent more flexible than the Duralyn balloon material used in the current dilatation catheters. Empira will be made available in selected sizes to a limited number of centers in Europe during the summer. A full European commercial launch of Empira is planned for Q4 2011.

Cordis also announced the launch in Europe of Radial Solutions, a portfolio for transradial interventions. New to the portfolio is the Cordis RadialSource Transradial Access Kit. RadialSource transradial sheaths are designed to provide cardiologists with atraumatic and smooth access to the radial artery during diagnostic and interventional procedures.

The RadialSource transradial sheath incorporates a new tapering design in conjunction with a lubricious coating, offering the benefits of low insertion force with a smooth atraumatic entry, while enabling stability during procedure and ease of removal. Physicians will be offered a choice of kit with a bare metal or a polymer-coated guide wire.

Cordis Radial Solutions encompass Cordis' well known guiding and diagnostic catheters with new specific radial shapes, transradial sheath introducer, guide wires and professional education training.

"Radial access, with much fewer bleeding complications, is becoming the dominant access site in many countries," said Douglas G. Fraser, MB, BChir, MRCP, DM, interventional cardiologist, Manchester Heart Centre, Manchester Royal Infirmary, U.K.

Related Content

Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Lutonix 035 Drug Coated Balloon Earns Additional FDA Premarket Approval
Technology | Drug-Eluting Balloons| August 29, 2017
C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (...
Merit Medical Announces Advanced Interventional Cardiology Transradial Intervention Education Course
News | Radial Access| August 23, 2017
Merit Medical Systems Inc. will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij,...
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons| July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
radial access, transradial access trial using anticoagulants
News | Radial Access| June 15, 2017
June 15, 2017 — In patients undergoing t...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study o
Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Overlay Init